• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SOLTA MEDICAL, INC. FRAXEL RE:STORE LASER SYSTEM; POWERED LASER SURGICAL INSTRUMENT WITH MICROBEAM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SOLTA MEDICAL, INC. FRAXEL RE:STORE LASER SYSTEM; POWERED LASER SURGICAL INSTRUMENT WITH MICROBEAM Back to Search Results
Model Number MCSR1500-D-INTL
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Burn(s) (1757)
Event Date 03/23/2018
Event Type  Injury  
Manufacturer Narrative
The burn paper test results have been requested yet not received.
 
Event Description
The patient received a full face treatment on (b)(6) 2018.During the treatment there were no errors and nothing out of the ordinary.On (b)(6) 2018 the patient noticed erythema residual scabbing.Additional information has been requested, yet not received, regarding the patient's current status.
 
Manufacturer Narrative
It was reported a patient experienced erythema and residual scabbing on the face post fraxel treatment.The customer reported no system errors or anything out of the ordinary occurring during treatment.System has software safeguards (such as a power on self-test) that will trigger error/event codes should system be outside of acceptable limits.Customer can also utilize the burn paper to confirm system laser is providing correct pattern/coverage.Customer did not perform a burn paper test and no review could be performed.According to fraxel user manual (p009220-02 rev.A), prolonged redness and blistering are known possible complication of fraxel treatment.Mild-moderate transient erythema is an expected response.However, if erythema is severe or persists significantly longer than expected, re-treatment should be avoided until the condition resolves.Reaction may vary on a patient-by-patient basis.Blistering or burns may develop over the treated areas.A review of the manufacturing records showed all requirements were met.The customer reported no system errors or anything out of the ordinary during treatment.Based on the available information, prolonged redness and blistering are known possible complication of fraxel treatment.Trending will be performed to monitor this issue.No further action is required at this time.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FRAXEL RE:STORE LASER SYSTEM
Type of Device
POWERED LASER SURGICAL INSTRUMENT WITH MICROBEAM
Manufacturer (Section D)
SOLTA MEDICAL, INC.
11720 north creek pkwy n suite
bothell WA 98011
MDR Report Key7486364
MDR Text Key107327348
Report Number3011423170-2018-00036
Device Sequence Number1
Product Code ONG
Combination Product (y/n)N
PMA/PMN Number
K091420
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 04/06/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/04/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberMCSR1500-D-INTL
Was Device Available for Evaluation? No
Date Manufacturer Received04/06/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
-
-